Chemcon Speciality Chemicals Limited (NSE: CHEMCON, BSE: 543233) is a Vadodara, Gujarat-based company in the Custom Synthesis and Specialty CDMO industry. With a market capitalisation of ₹733 Cr, it ranks #1,772 by market cap among the 6,197 Indian listed companies on FinBizNet, and #8 of 13 in Custom Synthesis and Specialty CDMO. At ₹202.01 (as of 16 Nov 2026), the share price is 15.8% below its 52-week high of ₹240.00 and 61.6% above its 52-week low of ₹125.00. The share price is down 12.8% over one year and up 5.9% over three months.
| Current Price | ₹202.01 |
|---|---|
| Market Cap | ₹733 Cr |
| NSE Symbol | CHEMCON |
| BSE Code | 543233 |
| Sector | Materials > Chemicals > Speciality Chemicals |
| Sub-Industry | Specialty Chemicals > Custom Synthesis and Specialty CDMO |
| P/E Ratio | 31.8 |
| Return on Equity | 4.80% |
| Return on Assets | 2.14% |
| 52-Week Range | ₹125.00 – ₹240.00 |
| 1-Year Price Change | -12.8% |
| 3-Month Price Change | +5.9% |
| Beta (1Y) | 0.59 |
| Dividend Yield | 6.35% |
| Headquarters | Vadodara, Gujarat |
| Website | cscpl.com |
| Revenue | ₹65 Cr |
|---|---|
| Net Profit | ₹8 Cr |
| Net Margin | 11.5% |
| EPS (Basic) | ₹2.05 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Chemcon Speciality Chemicals Limited reported revenue of ₹65 Cr in Q2 FY27, up 21.9% from ₹54 Cr in Q2 FY26 and down 1.6% from ₹66 Cr in Q1 FY27. It posted a net profit of ₹8 Cr for the quarter, against a net profit of ₹6 Cr in Q2 FY26 (up 30.8%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹54 Cr (Q1 FY26) to ₹75 Cr (Q4 FY26). The company was profitable in each of these 7 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q2 FY27 | ₹65 Cr | ₹8 Cr | 11.5% |
| Q1 FY27 | ₹66 Cr | ₹11 Cr | 16.5% |
| Q4 FY26 | ₹75 Cr | ₹6 Cr | 8.4% |
| Q3 FY26 | ₹57 Cr | ₹5 Cr | 8.9% |
| Q2 FY26 | ₹54 Cr | ₹6 Cr | 10.7% |
| Q1 FY26 | ₹54 Cr | ₹6 Cr | 11.9% |
| Q4 FY25 | ₹55 Cr | ₹4 Cr | 7.2% |
Standalone figures (₹ crore, XBRL filings).
Promoters held 74.47% of Chemcon Speciality Chemicals Limited's shares as of Sept 2026, unchanged from Sept 2025. Delivery averaged 60.2% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).
Chemcon Speciality Chemicals Limited engages in the manufacture and sale of specialty chemicals for pharmaceutical, agro-chemical, textile, personal care, construction, automotive, electronics, silanes, and oilfield chemicals industries in India and internationally. The company offers oilfield chemicals, including calcium bromide liquid, calcium bromide powder, sodium bromide solution, and zinc bromide solution; pharmaceutical chemicals, such as hexamethyl disilazane, trimethyl chlorosilane, hexamethyl disiloxane, bromobenzene, dibromomethane, and chloromethyl isopropyl carbonate; silanes comprising hexamethyl disilazane, trimethyl chlorosilane, and hexamethyl disiloxane; agro chemicals, including bromobenzene, ammonium chloride, and dibromomethane; and fragrance chemicals. It also provides contract development and manufacturing services. The company was incorporated in 1988 and is based in Vadodara, India.
1. Manufacturing of Specialised Chemicals-This segment manufactures specialized chemicals.
1. Manufacturing of Specialised Chemicals-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Anupam Rasayan India Ltd | ₹13,570 Cr | 79.6 | 5.76% | ₹806 Cr | +20.1% |
| Neogen Chemicals Limited (Neogen) | ₹8,322 Cr | 259.2 | 3.58% | ₹296 Cr | +93.4% |
| Prasol Chemicals Limited | ₹4,681 Cr | 58.1 | — | ₹413 Cr | — |
| Laxmi Organic Industries Ltd | ₹4,574 Cr | 57.2 | 4.08% | ₹1,083 Cr | -18.9% |
| Tatva Chintan Pharma Chem Ltd | ₹3,871 Cr | 92.5 | 5.53% | ₹217 Cr | +12.2% |
| Paushak Ltd. | ₹1,487 Cr | 38.1 | 8.22% | ₹89 Cr | — |
| Sunshield Chemicals Ltd. | ₹833 Cr | 25.2 | 17.02% | — | +12.6% |
| Chemcon Speciality Chemicals Limited | ₹733 Cr | 31.8 | 4.80% | ₹65 Cr | -12.8% |
| Resonance Specialties Ltd. | ₹327 Cr | 31.5 | 15.15% | — | +203.4% |
Listed by market capitalisation. Ratios are shown for context only.
Chemcon Speciality Chemicals Limited is trading at ₹202.01, with a market capitalisation of ₹733 Cr.
Chemcon Speciality Chemicals Limited operates in the Materials > Chemicals > Speciality Chemicals space (Specialty Chemicals > Custom Synthesis and Specialty CDMO).
Chemcon Speciality Chemicals Limited has a P/E of 31.8 and a return on equity of 4.80%.
Chemcon Speciality Chemicals Limited is listed on the NSE under the symbol CHEMCON and on the BSE under the scrip code 543233.
Chemcon Speciality Chemicals Limited's share price is down 12.8% over one year and up 5.9% over three months. Its 52-week range is ₹125.00 to ₹240.00.
In Q2 FY27, Chemcon Speciality Chemicals Limited reported revenue of ₹65 Cr and net profit of ₹8 Cr, with basic EPS of ₹2.05 (standalone, parsed from the company's exchange filing).
Chemcon Speciality Chemicals Limited reported revenue of ₹65 Cr in Q2 FY27, up 21.9% from ₹54 Cr in Q2 FY26 and down 1.6% from ₹66 Cr in Q1 FY27.
Promoters held 74.47% of Chemcon Speciality Chemicals Limited's shares as of Sept 2026, unchanged from Sept 2025.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.